A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica
-
By
-
Edoardo Conticini
-
Raffaele Truscelli
-
Silvia Grazzini
-
Paolo Falsetti
-
Caterina Baldi
-
Alessandra Cartocci
-
Luca Cantarini
-
Bruno Frediani
-
February 26, 2026
-
Clinical Scorecard: A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica
At a Glance
| Category | Detail |
|---|
| Condition | Polymyalgia Rheumatica (PMR) |
| Key Mechanisms | Short-term glucocorticoids (prednisone) and methotrexate as a combined treatment strategy. |
| Target Population | Patients with recently diagnosed PMR (< 4 weeks) without subclinical giant cell arteritis. |
| Care Setting | Single-center, outpatient rheumatology clinic. |
Key Highlights
- PMR is common in the elderly and often requires long-term glucocorticoid treatment.
- A high rate of relapses occurs, necessitating research into steroid-sparing agents.
- Methotrexate may be effective when administered early in conjunction with glucocorticoids.
- The study aims to achieve PDN-free remission at 26 weeks and sustained remission at 52 weeks.
- Ultrasound evaluation is crucial for diagnosis and exclusion of giant cell arteritis.
Guideline-Based Recommendations
Diagnosis
- Fulfillment of ACR/EULAR classification criteria with ultrasound.
Management
- Start with 25 mg/day of prednisone, tapering to 0 within 20 weeks, and administer methotrexate at 0.2 mg/kg/week.
Monitoring & Follow-up
- Re-evaluate disease activity, prednisone and methotrexate dosage, and markers of inflammation at 26 and 52 weeks.
Risks
- Potential adverse events from methotrexate and the risk of relapse requiring increased glucocorticoid dosage.
Patient & Prescribing Data
Patients diagnosed with PMR within 4 weeks and without contraindications to methotrexate.
Combination therapy with methotrexate and short-term glucocorticoids may improve remission rates.
Clinical Best Practices
- Employ a treat-to-target approach for managing PMR.
- Utilize ultrasound for accurate diagnosis and monitoring.
- Consider early initiation of methotrexate to reduce glucocorticoid dependency.
References
